✦ LIBER ✦

A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial

✍ Scribed by Daigo Yamamoto; Satoru Iwase; Kaoru Kitamura; Hiroki Odagiri; Chizuko Yamamoto; Yoshinori Nagumo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of capecitabine and trast

✍ Takanori Ishida; Takayoshi Kiba; Motohiro Takeda; Kotone Matsuyama; Satoshi Tera 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 367 KB

Multicenter phase II study of trastuzuma

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

Phase I trial of oral mTOR inhibitor eve

✍ Guy Jerusalem; Angelica Fasolo; Veronique Dieras; Fatima Cardoso; Jonas Bergh; L 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 326 KB

Phase II trial of a novel capecitabine d

✍ Devika Gajria; Joseph Gonzalez; Kimberly Feigin; Sujata Patil; Carol Chen; Maria 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 219 KB

A phase I/II prospective, single arm tri

✍ G. Somlo; C. L. Martel; S. K. Lau; P. Frankel; C. Ruel; L. Gu; A. Hurria; C. Chu 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 229 KB

A phase II trial of trastuzumab plus wee

✍ Stacy Moulder; Hailun Li; Molin Wang; William J. Gradishar; Edith A. Perez; Jose 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 250 KB